Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Apr;99(4):513-518.
doi: 10.1111/cge.13905. Epub 2021 Jan 16.

Biallelic loss-of-function HACD1 variants are a bona fide cause of congenital myopathy

Affiliations
Case Reports

Biallelic loss-of-function HACD1 variants are a bona fide cause of congenital myopathy

Lia Abbasi-Moheb et al. Clin Genet. 2021 Apr.

Abstract

Congenital myopathies include a wide range of genetically determined disorders characterized by muscle weakness that usually manifest shortly after birth. To date, two different homozygous loss-of-function variants in the HACD1 gene have been reported to cause congenital myopathy. We identified three patients manifesting with neonatal-onset generalized muscle weakness and motor delay that carried three novel homozygous likely pathogenic HACD1 variants. The two of these changes (c.373_375+2delGAGGT and c.785-1G>T) were predicted to introduce splice site alterations, while one is a nonsense change (c.458G>A). The clinical presentation of our and the previously reported patients was comparable, including the temporally progressive improvement that seems to be characteristic of HACD1-related myopathy. Our findings conclusively confirm the implication of HACD1 in the pathogenesis of congenital myopathies, corroborate the main phenotypic features, and further define the genotypic spectrum of this genetic form of myopathy. Importantly, the genetic diagnosis of HACD1-related myopathy bears impactful prognostic value.

Keywords: HACD1; biallelic variants; congenital myopathy; truncating variants.

PubMed Disclaimer

References

REFERENCES

    1. Amburgey K, McNamara N, Bennett LR, McCormick ME, Acsadi G, Dowling JJ. Prevalence of congenital myopathies in a representative pediatric United States population. Ann Neurol. 2011;70(4):662-665. https://doi.org/10.1002/ana.22510.
    1. Gonorazky HD, Bönnemann CG, Dowling JJ. The genetics of congenital myopathies. Handbook of Clinical Neurology. Vol 148. Netherlands: Elsevier B.V; 2018:549-564. https://doi.org/10.1016/B978-0-444-64076-5.00036-3.
    1. Benarroch L, Bonne G, Rivier F, Hamroun D. The 2020 version of the gene table of neuromuscular disorders (nuclear genome). Neuromuscul Disord. 2019;29(12):980-1018. https://doi.org/10.1016/j.nmd.2019.10.010.
    1. Darras BT, Jones HR, Ryan MM, De Vivo DC. Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach: Second Edition. Germany: Elsevier Inc.; 2014.
    1. Muhammad E, Reish O, Ohno Y, et al. Congenital myopathy is caused by mutation of HACD1. Hum Mol Genet. 2013;22(25):5229-5236. https://doi.org/10.1093/hmg/ddt380.

Publication types

MeSH terms

LinkOut - more resources